Mitch Wolfe, MD, former Chief Medical Officer of CDC, offers some insights on mpox including the benefits of declaring a global emergency, disease transmission, and considerations for both the US public and clinicians.
Mitch Wolfe, MD
Advertisement
Wolfe is vice president of Global Engagement and Governance, Ginkgo Bioworks and former Chief Medical Officer at the CDC.
Articles by Mitch Wolfe, MD
Advertisement
Latest Updated Articles
The Significance of WHO Declaring Mpox a Global EmergencyPublished: August 16th 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Rapid HCV Test Provides Opportunity for Single Visit Diagnosis and Treatment Encounters
2
No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy
3
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
4
Streamlining IV-to-Oral Transitions in Pneumonia Care: Duration, Tailoring, and Post-Discharge Considerations
5
